Results 301 to 310 of about 60,451 (335)
Some of the next articles are maybe not open access.

Progress in Standardizing Antifungal Susceptibility Tests

Clinics in Laboratory Medicine, 1989
In vitro tests of antifungal agents are receiving increasing attention as important procedures for the clinical laboratory. As antifungal agents proliferate, it will become more and more valuable to have available antifungal susceptibility tests to aid in treatment selections based on the specific activities of different drugs against a patient's own ...
openaire   +2 more sources

Etest for antifungal susceptibility testing of yeasts

Diagnostic Microbiology and Infectious Disease, 1994
Comparison [+/- 1 dilution between minimum inhibitory concentrations (MICs)] of fluconazole and flucytosine Etest MICs of 10 candidate quality control yeast isolates and 78 clinical isolates demonstrated good agreement (> or = 90%) with the reference method (National Committee for Clinical Laboratory Standards document M27-P).
openaire   +2 more sources

Susceptibility Testing Methods of Antifungal Agents

2005
Several methods for testing antifungal susceptibility are currently utilized. Minimum inhibitory concentrations can be tested using standardized noncommercial or commercial tests. Fungicidal testing includes either in vitro methods, such as time-kill or minimum fungicidal testing methods, or animal models.
openaire   +2 more sources

Antifungal Susceptibility Testing and Therapy

2009
The development of new therapies to treat fatal diseases is creating an increasing number of patients who have predisposing factors for infections by opportunistic yeasts. The rise in the prevalence of fungal infections has been the drive to develop and license several new antifungal agents such as new formulations of polyenes, new triazole agents and ...
Manuel Cuenca-Estrella   +1 more
openaire   +1 more source

Susceptibility testing and antifungal agents

Clinical Microbiology Newsletter, 1980
The microbiology laboratory plays a key role in establishing the diagnosis of systemic fungal infections, by recovering fungi in culture and/or detecting fungal constituents or metabolic products in body fluids. The laboratory's role in proriding pertinent information to help manage patients with documented systemic fungal infections is, however, less ...
openaire   +1 more source

Antifungal Susceptibility Testing of Dermatophytes

2021
In order to help guide treatment, antifungal susceptibility testing is often performed in clinical microbiology laboratories. The results of these in vitro assays are used by clinicians to change therapy should resistance be detected, continue with current regimens with susceptible results, and as an aide in determining possible reasons for treatment ...
openaire   +1 more source

Standardization of antifungal susceptibility testing

Medical Mycology, 1992
J N, Galgiani   +3 more
openaire   +2 more sources

Antifungal drug susceptibility testing

Medical Mycology, 1994
J, Van Cutsem   +6 more
openaire   +2 more sources

Antifungal susceptibility testing with dermatophytes.

Mycoses, 1992
The determination of the in vitro activity of antimycotics against dermatophytes has for long been considered as irrelevant from a practical point of view. Recently, however, this approach has been questioned. Various different tests such as agar diffusion test, agar dilution test and broth dilution test can be used for the determination of minimum ...
A, Georgii, H C, Korting
openaire   +1 more source

Antifungal susceptibility testing

2004
During the past few decades, advances in medical technology and the development of new diagnostic and treatment approaches have increased the life expectancy of critically ill patients. The global human immunodeficiency virus (HIV) epidemic has resultedin an increase in severely ill immunocompromised hospitalized patients, accompanied by more reports ...
openaire   +1 more source

Home - About - Disclaimer - Privacy